Metabolic Syndrome and Its Component Factors Among Corporate Company Employees in Kampala Uganda
Jemimah Kiboss Kyeyune, Zandile June-Rose Mchiza, Mwambi Bashir, Prossy Merab Ingabire, Florence Wamuyu Githinji, Florence Nakaggwa, Ivan Gabriel Busulwa, Rose Clarke Nanyonga

TL;DR
This study finds that metabolic syndrome is common among corporate employees in Kampala, Uganda, with obesity and blood pressure being key factors.
Contribution
The study identifies key determinants of metabolic syndrome in a corporate employee population in Uganda using cross-sectional survey data.
Findings
The prevalence of metabolic syndrome was 22.8% using NCEP criteria and 28.4% using IDF criteria.
Age, BMI, and perceived cardiometabolic risk were significant determinants of metabolic syndrome.
Central obesity and low HDL-C explained most of the variance in metabolic dysregulation.
Abstract
Metabolic syndrome (MetS), a cluster of metabolic dysregulations indicative of increased cardiometabolic risk is on the rise in Sub-Saharan Africa. The study aimed to determine the prevalence of MetS and its components, among corporate employees in Kampala, Uganda. A cross-sectional survey was undertaken among 408 adults who were employees from seven corporate companies in Kampala, using the WHO STEPwise NCD screening approach. Metabolic syndrome was measured using the National Cholesterol Education Program Adult Treatment Panel (ATPIII) and the International Diabetes Federation (IDF) criteria with the waist circumference (WC) cut-off points adapted for Sub-Saharan African populations. The mean population age (standard deviation [SD]) of the respondents was 34years (± 8.87) years and 52% of them were females. The prevalence of MetS was 22.8% (NCEP ATPIII) and 28.4% (IDF). Of the…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDiabetes, Cardiovascular Risks, and Lipoproteins · Liver Disease Diagnosis and Treatment
